|
|
Transcripts of coding genes that showed significantly decreased expression in muscle. |
DESeq2 (version 1.24.0). Transcripts with a false-discovery rate adjusted p-value less than 0.05 were considered significantly differentially expressed. |
WBPaper00062325:muscle_depleted_coding-RNA
|
|
|
Transcripts that showed significantly increased expression in csr-1a(tor159) comparing to in N2 at 25C. |
DESeq2, fold change > 2, p-value < 0.05. |
WBPaper00061753:csr-1(tor159)_upregulated_25C
|
|
|
Transcripts that showed significantly increased expression in aak-1(tm1944);aak-2(ok524) animals comparing to in N2. |
DEseq 1.18.0, adjusted p-value < 0.05. |
WBPaper00056471:aak-1(tm1944);aak-2(ok524)_upregulated
|
|
|
Transcripts that showed significantly increased expression in cco-1(RNAi) comparing to in vector control animals. |
The limma package47 was used for differential expression. Genes with a Benjamini-Hochberg adjusted P-value <0.05 and an absolute log fold change of 2 were considered differentially expressed. |
WBPaper00053402:cco-1(RNAi)_upregulated
|
|
|
Genes which expression is changed in isp-1;ctb-1 mutant and is not affected by developmental klf-1 RNAi, but is brought to wild type levels by klf-1 RNAi in adulthood. |
N.A. |
WBPaper00059194:klf-1(RNAi)_regulated
|
|
|
Transcripts that showed significantly increased expression in clk-1(qm30) comparing to in N2. |
Differential gene expression analysis was performed using the quasi-likeli-hood framework in edgeR package v. 3.20.1 in R v. 3.4.1. |
WBPaper00053810:clk-1(qm30)_upregulated
|
|
|
Transcripts that showed significantly increased expression in isp-1(qm150) comparing to in N2. |
Differential gene expression analysis was performed using the quasi-likeli-hood framework in edgeR package v. 3.20.1 in R v. 3.4.1. |
WBPaper00053810:isp-1(qm150)_upregulated
|
|
|
Transcripts that showed significantly increased expression in nuo-6(qm200) comparing to in N2. |
Differential gene expression analysis was performed using the quasi-likeli-hood framework in edgeR package v. 3.20.1 in R v. 3.4.1. |
WBPaper00053810:nuo-6(qm200)_upregulated
|
|
|
Transcripts that showed significantly increased expression in BAT525 [hmg-3 (tm2539) / dpy-5(e61) unc-13(e1091) I.] comparing to in N2 at 1-day post L4 adult hermaphrodite stage. |
DESeq 2, fold change > 4, adjusted p-value < 0.05. |
WBPaper00055013:hmg-3(bar24)_upregulated
|
|
|
Transcripts that showed altered expression from P0 to F2 generation animals after N2 parental generation were treated with antimycin, but not in damt-1(gk961032) P0 to F2 animals after the parenal generaton were treated with antimycin. |
N.A. |
WBPaper00055862:antimycin_damt-1(gk961032)_regulated
|
|
|
Transcripts that showed significantly increased expression in nuo-6(qm200) comparing to in N2. |
EdgeR v. 3.20.2, fold change > 2. |
WBPaper00055941:nuo-6(qm200)_upregulated
|
|
|
Up-regulated genes (fold change > 1.5) in two CoQ-deficient clk-1 mutant strains (e2519, qm30) compared to wild types N2. |
Fold-changes of intensities were calculated from the arithmetic mean of gene expression values between experimental and corresponding control group. Fold change >= 1.5 was used as cut-off. |
WBPaper00045774:clk-1_upregulated
|
|
|
Genes found to be regulated by low-copy overexpression of sir-2.1 with p < 0.014. |
N.A. |
WBPaper00026929:sir-2.1_overexpression_regulated
|
|
|
Transcripts that showed significantly increased expression in him-17(me24) comparing to in N2 animals. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00064769:him-17(me24)_upregulated
|
|
|
Transcripts with significantly increased expression in isp-1(qm150) vs. N2, and in isp-1(qm150) ced-4(n1162) vs. ced-4(n1162). |
Comparisons of each genotype were compared to the wild-type using the Empirical Base (Wright & Simon) algorithm and fold changes were represented on a log2 scale. A threshold of p < 0.05 and a fold change of 1.3 (log2) was set to determine differentially expressed targets. |
WBPaper00045263:isp-1(qm150)_upregulated
|
|
|
Transcripts with significantly increased expression in nuo-6(qm200) vs. N2, and in nuo-6(qm200);ced-4(n1162) vs. ced-4(n1162). |
Comparisons of each genotype were compared to the wild-type using the Empirical Base (Wright & Simon) algorithm and fold changes were represented on a log2 scale. A threshold of p < 0.05 and a fold change of 1.3 (log2) was set to determine differentially expressed targets. |
WBPaper00045263:nuo-6(qm200)_upregulated
|
|
|
Transcripts that showed significantly increased expression in atfs-1(et15) comparing to in N2. |
EdgeR v. 3.20.2, fold change > 2. |
WBPaper00055941:atfs-1(et15)_upregulated
|
|
|
Significantly upregulated genes from cyc-1(RNAi) microarrays using SAM algorithm with an FDR < 0.1 from adult-only chips. |
SAM algorithm with an FDR < 0.1. |
WBPaper00033065:cyc-1(RNAi)_upregulated
|
|
|
Significantly up-regulated genes (>= 1.5-fold change, q value < 0.05) in blmp-1(tm548) mutant versus N2 L3 larvae as obtained from RNA sequencing analysis (n = 3). |
Differential gene expression was performed with cuffdiff - which is part of the cufflinks package (v2.0.2) Genes with a FPKM value >0.5 in at least one of the N2 and blmp1 samples were considered expressed. Those with a q-value < 0.05 and fold change > +/- 1.5 were classified as differentially expressed. |
WBPaper00045017:blmp-1(tm548)_upregulated
|
|
|
Genes found to be regulated in daf-16(mgDf50) by resveratrol treatment with p < 0.01. |
N.A. |
WBPaper00026929:Resveratrol_regulated_daf-16
|
|
|
Transcripts that showed significantly increased expression in diploid N2 animals after exposure to 5 uM doxorubicin for 72 hours at 15C from L1 to L4 larve stage. |
DESeq2 R package (1.20.0), fold change > 2, and FDR < 0.05. |
WBPaper00066110:Doxorubicin_upregulated_diploid
|
|
|
Transcripts that showed significantly increased expression in tetraploid N2 comparing to diploid N2 animals at L4 larva stage. |
DESeq2 R package (1.20.0), fold change > 2, and FDR < 0.05. |
WBPaper00066110:tetraploid_vs_diploid_upregulated
|
|
0.5% glucose supplemented OP50 diet. |
Transcripts that showed significantly increased expression in hyl-2(tm2031) fed with glucose diet, comparing to in hyl-2(tm2031) when fed with OP50 only diet. |
Cufflinks was used to identify the genes in glucose-fed C. elegans with significant alteration in their expressions compared to wild-type C. elegans. The transcripts passing the significance test [False discovery rate (FDR) adjusted P-value to be < 0.05] were examined further for their abundance fold change between the conditions. |
WBPaper00049920:Glucose-Diet_upregulated_hyl-2(tm2031)
|
|
|
Genes that are significantly down regulated after 24 hour exposure to H2S. |
Data were RMA normalized and probe-level data were Summarized with the NimbleScan software. Genes with weak signal intensity across all groups and those with low variability across samples were excluded from further analysis. Each H2S-treated sample was statistically compared to a matched untreated control using the Bioconductor package limma. The false discovery rate (FDR) method of Benjamini and Hochberg was used to adjust p-values for multiple testing. An adjusted p-value <= 0.05 was used to define differential expression. |
WBPaper00040285:H2S_24hr_downregulated
|
|
|
Transcripts that showed significantly decreased expression in numr-1/2(RNAi) animals comparing to control RNAi animals, at late L3 larva stage. |
DESeq2, v1.12.0, fold change > 2, FDR < 0.05 |
WBPaper00057068:numr-1(RNAi)_downregulated
|
|
|
Transcripts that showed significantly increased expression in hsp-6(mg585) comparing to in N2 at L4 larva stage. |
EdgeR, fold change > 2, FDR < 0.001. |
WBPaper00056290:hsp-6(mg585)_upregulated
|
|
|
Transcripts that showed significantly increased expression in diploid N2 animals after exposure to 5uM cisplatin for 72 hours at 15C from L1 to L4 larve stage. |
DESeq2 R package (1.20.0), fold change > 2, and FDR < 0.05. |
WBPaper00066110:Cisplatin_upregulated_diploid
|
|
|
Genes identified as up-regulated at a 5% false discovery rate through RNAseq experiments with three tatn-1(qd182) and three N2 RNA samples. |
ANOVA with FDR <= 0.05. |
WBPaper00044656:tatn-1(qd182)_upregulated
|
|
|
Transcripts that showed significantly increased expression in mrps-5(RNAi) animals comparing to animals injected with empty vector. |
Differential expression was assessed using a Partial least-squares discriminant analysis (PLS-DA) using mixomics setting a variable of importance (VIP) score of greater than 1 as significant. |
WBPaper00059328:mrps-5(RNAi)_upregulated_mRNA
|
|
|
Transcripts that showed significantly decreased expression in numr-1/2(RNAi) animals treated with 300uM CdCl2 from L1 to late L3 larva stage, comparing to control RNAi animals with the same Cadmium treatment. |
DESeq2, v1.12.0, fold change > 2, FDR < 0.05 |
WBPaper00057068:numr-1(RNAi)_downregulated_Cadmium
|
